UCL Business PLC is the technology-transfer company of University College London Hospital NHS Foundation Trust in

London London is the capital and List of urban areas in the United Kingdom, largest city of England and the United Kingdom, with a population of just under 9 million. It stands on the River Thames in south-east England at the head of a estuary dow ...

, England. Its head office is on

Tottenham Court Road Tottenham Court Road (occasionally abbreviated as TCR) is a major road in Central London, almost entirely within the London Borough of Camden. The road runs from Euston Road in the north to St Giles Circus in the south; Tottenham Court Road t ...

in the

London Borough of Camden The London Borough of Camden () is a London borough in Inner London. Camden Town Hall, on Euston Road, lies north of Charing Cross. The borough was established on 1 April 1965 from the area of the former boroughs of Hampstead, Holborn, and ...

History

UCL's first technology-transfer company was named in the Pandora papers for the widespread use of offshore companies and use of third party ownership and payments to avoid UCL and government oversight. UCL Ventures merged with the technology-transfer company of the Royal Free Hospital, Freemedic plc (founded in 1993) to form UCL Biomedica PLC. The former UCL Business had been established to force academics through the use of NDA's to sign over any IP to UCL, thereby aiding the development of commercially valuable technologies arising from UCL, whilst UCL BioMedica had been established to commercialise opportunities arising from UCL's biomedical research strengths, as well as to conduct clinical trials. The integration of the two technology transfer activities created a single organisation focused on delivering the complete commercialisation process from patent registration and support for the creation of new businesses, through to licensing and sales of technologies to industry partners. UCLB provided advice and a grant support to Siavash Haroun Mahdavi in helping him to establish the robotics company Complex Matters. In January 2011, BioVex, a cancer vaccines company spun-out of UCL in 1999, was sold to

Amgen Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen was established in T ...

for $1 billion.

Operations

Spin-out companies

UCLB has equity stake in all of its companies, the majority being spin-outs arising from technologies developed across the full range of faculties within UCL, including biomedical, biotechnology, engineering, mathematics, physical sciences and build environment companies. These include Ark Therapeutics Ltd, Arrow Therapeutics Ltd, Biovex Ltd, Canbex, Domainex Ltd, Evexar Medical Ltd, Genex Biosystems, Intercytex, Medic-to-Medic, Pentraxin Therapeutics, PolyMASC Pharmaceuticals PLC, Proaxon, Spirogen Ltd, Stanmore Implants Worldwide Ltd, Advanced Design Technology, AS Built Solutions, Bloomsbury DSP, Endomagnetics, EuroTempest, Ixico, Quantemol, Senceive, Space Syntax, Zinwave.

External links

UCL Business

References

{{DEFAULTSORT:Ucl Business Technology transfer Technology companies of the United Kingdom Companies based in the London Borough of Camden University College London